Christopher Pazdan - Mar 17, 2025 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Role
Chief Operating Officer
Signature
/s/ Christopher Pazdan
Stock symbol
KRMD
Transactions as of
Mar 17, 2025
Transactions value $
-$41,100
Form type
4
Date filed
3/21/2025, 04:34 PM
Previous filing
Sep 30, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRMD Common Stock Options Exercise +5.06K +11.32% 49.8K Mar 17, 2025 Direct F3
transaction KRMD Common Stock Tax liability -$4.74K -1.64K -3.3% $2.89 48.1K Mar 17, 2025 Direct
transaction KRMD Common Stock Options Exercise +36.3K +75.46% 84.5K Mar 19, 2025 Direct F1, F3
transaction KRMD Common Stock Tax liability -$36.4K -12.8K -15.21% $2.83 71.6K Mar 19, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRMD Restricted Stock Units Options Exercise -5.06K -25% 15.2K Mar 17, 2025 Common Stock 5.06K Direct F3, F4
transaction KRMD Performance Share Unit Options Exercise -36.3K -100% 0 Mar 19, 2025 Common Stock 36.3K Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents settlement of vested performance share units ("PSUs") in shares of the Issuer's common stock.
F2 Represents shares withheld to satisfy tax obligations upon settlement of vested PSUs.
F3 Restricted stock units and performance share units are paid out in shares of common stock on a one-for-one basis.
F4 This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations.
F5 These performance share units were granted on April 24, 2024. Vesting was dependent upon the achievement by Issuer of certain performance criteria as of December 31, 2024.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.